01692-A: Accurate Diagnosis of Mast Cell Tumor Metastasis

Grant Status: Closed

Grant Amount: $12,960
Arthur Donohue-Rolfe, PhD; Tufts University
February 1, 2012 - January 31, 2013

Sponsor(s): Gordon Setter Club of America, Siberian Husky Club of America, Worcester County Kennel Club

Breed(s): -All Dogs
Research Program Area: Oncology
Donate to Support this Research Program Area

Project Summary

This study addresses the need to develop biomarkers specific to canine cutaneous mast cell tumors (MCT) that can be used to quantitatively, efficiently and accurately predict tumor behavior. In dogs, mast cell tumors are one of the most common cancers, comprising up to 21% of all canine skin cancers. Clinical outcomes of cutaneous MCT can vary from easily cured isolated tumors to fatal metastases. Failure to accurately predict the outcome can result in patients being subjected to painful and expensive treatments unnecessarily or, conversely, not getting the intensive treatment they need. The current markers for MCT only accurately predict outcome in a small number of patients. Moreover, these techniques are subjective and labor-intensive. A major effort is underway to develop molecular and biological tests for diagnosis and prognosis in human oncology. We are in the process of applying this approach to canine cutaneous MCT, through active collaborations between pathologists at the Tufts Cummings School of Veterinary Medicine and molecular biologists at the Broad Institute who have identified a number of unique potential biomarkers for canine MCT.


None at this time.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2018 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software